BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31614872)

  • 1. Cerebrospinal Fluid MicroRNA Signatures as Diagnostic Biomarkers in Brain Tumors.
    Kopkova A; Sana J; Machackova T; Vecera M; Radova L; Trachtova K; Vybihal V; Smrcka M; Kazda T; Slaby O; Fadrus P
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31614872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and standardization of microRNA profiling in serum and cerebrospinal fluid in dogs suffering from non-infectious inflammatory CNS disease.
    Cirera S; Andersen-Ranberg EU; Langkilde S; Aaquist M; Gredal H
    Acta Vet Scand; 2019 Dec; 61(1):57. PubMed ID: 31796072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor and Cerebrospinal Fluid microRNAs in Primary Central Nervous System Lymphomas.
    Zajdel M; Rymkiewicz G; Sromek M; Cieslikowska M; Swoboda P; Kulinczak M; Goryca K; Bystydzienski Z; Blachnio K; Ostrowska B; Borysiuk A; Druzd-Sitek A; Walewski J; Chechlinska M; Siwicki JK
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31731456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.
    Drusco A; Bottoni A; Laganà A; Acunzo M; Fassan M; Cascione L; Antenucci A; Kumchala P; Vicentini C; Gardiman MP; Alder H; Carosi MA; Ammirati M; Gherardi S; Luscrì M; Carapella C; Zanesi N; Croce CM
    Oncotarget; 2015 Aug; 6(25):20829-39. PubMed ID: 26246487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity.
    Teplyuk NM; Mollenhauer B; Gabriely G; Giese A; Kim E; Smolsky M; Kim RY; Saria MG; Pastorino S; Kesari S; Krichevsky AM
    Neuro Oncol; 2012 Jun; 14(6):689-700. PubMed ID: 22492962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma.
    Baraniskin A; Kuhnhenn J; Schlegel U; Maghnouj A; Zöllner H; Schmiegel W; Hahn S; Schroers R
    Neuro Oncol; 2012 Jan; 14(1):29-33. PubMed ID: 21937590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma.
    Bowden M; Zhou CW; Zhang S; Brais L; Rossi A; Naudin L; Thiagalingam A; Sicinska E; Kulke MH
    Oncotarget; 2017 Aug; 8(33):54331-54344. PubMed ID: 28903345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Customized Quantitative PCR MicroRNA Panel Provides a Technically Robust Context for Studying Neurodegenerative Disease Biomarkers and Indicates a High Correlation Between Cerebrospinal Fluid and Choroid Plexus MicroRNA Expression.
    Wang WX; Fardo DW; Jicha GA; Nelson PT
    Mol Neurobiol; 2017 Dec; 54(10):8191-8202. PubMed ID: 27900678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
    Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
    Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
    [No Abstract]   [Full Text] [Related]  

  • 12. Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms.
    Braoudaki M; Lambrou GI; Giannikou K; Milionis V; Stefanaki K; Birks DK; Prodromou N; Kolialexi A; Kattamis A; Spiliopoulou CA; Tzortzatou-Stathopoulou F; Kanavakis E
    J Hematol Oncol; 2014 Dec; 7():96. PubMed ID: 25551588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA expression profiling of cerebrospinal fluid in patients with aneurysmal subarachnoid hemorrhage.
    Stylli SS; Adamides AA; Koldej RM; Luwor RB; Ritchie DS; Ziogas J; Kaye AH
    J Neurosurg; 2017 Apr; 126(4):1131-1139. PubMed ID: 27128592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA based theranostics for brain cancer: basic principles.
    Petrescu GED; Sabo AA; Torsin LI; Calin GA; Dragomir MP
    J Exp Clin Cancer Res; 2019 May; 38(1):231. PubMed ID: 31142339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlapping MicroRNA Expression in Saliva and Cerebrospinal Fluid Accurately Identifies Pediatric Traumatic Brain Injury.
    Hicks SD; Johnson J; Carney MC; Bramley H; Olympia RP; Loeffert AC; Thomas NJ
    J Neurotrauma; 2018 Jan; 35(1):64-72. PubMed ID: 28762893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of microRNA-129-2-3p and microRNA-935 in plasma and brain tissue of human refractory epilepsy.
    Sun Y; Wang X; Wang Z; Zhang Y; Che N; Luo X; Tan Z; Sun X; Li X; Yang K; Wang G; Luan L; Liu Y; Zheng X; Wei M; Cheng H; Yin J
    Epilepsy Res; 2016 Nov; 127():276-283. PubMed ID: 27689807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.
    Sørensen SS; Nygaard AB; Christensen T
    Transl Neurodegener; 2016; 5():6. PubMed ID: 26981236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes.
    Yagi Y; Ohkubo T; Kawaji H; Machida A; Miyata H; Goda S; Roy S; Hayashizaki Y; Suzuki H; Yokota T
    Neurosci Lett; 2017 Jan; 636():48-57. PubMed ID: 27780738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors.
    Kopkova A; Sana J; Fadrus P; Slaby O
    Clin Chem Lab Med; 2018 May; 56(6):869-879. PubMed ID: 29451858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.